Emerald Health Therapeutics (EMHTF) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EMHTF Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Emerald Health Therapeutics manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Sep 30 2019) (Jun 30 2019) 0 (Dec 31 2018)
Assets
Cash And Cash Equivalents1.93
Cash & Short-term Investments1.00
Other Current Assets10.11
Total Current Assets12.05
Equipment/Property/Plant Net31.71
Goodwill net0.13
Other Assets, Noncurrent76.00
Total Assets119.97
Liabilities
Other Liabilities, Current19.68
Total Current Liabilities19.68
Total Long-term Debt0.00
Other liabilities, Noncurrent16.78
Total Liabilities40.95
Stockholders' Equity
Total Stockholder's Equity0.59
Liabilities & Stockholder's Equity119.97
4 historic quarters locked

Sign in to unlock the full Emerald Health Therapeutics balance sheet history.

About EMHTF Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.